Malango T Msukwa1,2, Olivia Keiser1, Andreas Jahn3, Joep J van Oosterhout4,5, Andrew Edmonds6, Nozgechi Phiri1,2, Ronald Manjomo2, Mary-Ann Davies7, Janne Estill1,8. 1. Institute of Global Health, University of Geneva, Geneva, Switzerland. 2. Baobab Health Trust, Lilongwe, Malawi. 3. Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi. 4. Dignitas International, Zomba, Malawi. 5. Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi. 6. The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 7. Centre of Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa. 8. Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, Switzerland.
Abstract
OBJECTIVE: To assess the association between timing of maternal combination ART (cART) initiation and stillbirth among HIV-infected pregnant women in Malawi's Option B+ programme. METHODS: Cohort study of HIV-infected pregnant women delivering singleton live or stillborn babies at ≥28 weeks of gestation using routine data from maternity registers between 1 January 2012 and 30 June 2015. We defined stillbirth as death of a foetus at ≥28 weeks of gestation. We report proportions of stillbirth according to timing of maternal cART initiation (before pregnancy, 1st or 2nd trimester, or 3rd trimester or labour). We used logistic regression, with robust standard errors to account for clustering of women within health facilities, to investigate the association between timing of cART initiation and stillbirth. RESULTS: Of 10 558 mother-infant pairs abstracted from registers, 8380 (79.4%) met inclusion criteria. The overall rate of stillbirth was 25 per 1000 deliveries (95% confidence interval 22-29). We found no significant association between timing of maternal cART initiation and stillbirth. In multivariable models, older maternal age, male sex of the infant, breech vaginal delivery, delivery at < 34 weeks of gestation and experience of any maternal obstetric complication were associated with higher odds of stillbirth. Deliveries managed by a mission hospital or health centre were associated with lower odds of stillbirth. CONCLUSION: Pregnant women's exposure to cART, regardless of time of its initiation, was not associated with increased odds of stillbirth.
OBJECTIVE: To assess the association between timing of maternal combination ART (cART) initiation and stillbirth among HIV-infected pregnant women in Malawi's Option B+ programme. METHODS: Cohort study of HIV-infected pregnant women delivering singleton live or stillborn babies at ≥28 weeks of gestation using routine data from maternity registers between 1 January 2012 and 30 June 2015. We defined stillbirth as death of a foetus at ≥28 weeks of gestation. We report proportions of stillbirth according to timing of maternal cART initiation (before pregnancy, 1st or 2nd trimester, or 3rd trimester or labour). We used logistic regression, with robust standard errors to account for clustering of women within health facilities, to investigate the association between timing of cART initiation and stillbirth. RESULTS: Of 10 558 mother-infant pairs abstracted from registers, 8380 (79.4%) met inclusion criteria. The overall rate of stillbirth was 25 per 1000 deliveries (95% confidence interval 22-29). We found no significant association between timing of maternal cART initiation and stillbirth. In multivariable models, older maternal age, male sex of the infant, breech vaginal delivery, delivery at < 34 weeks of gestation and experience of any maternal obstetric complication were associated with higher odds of stillbirth. Deliveries managed by a mission hospital or health centre were associated with lower odds of stillbirth. CONCLUSION: Pregnant women's exposure to cART, regardless of time of its initiation, was not associated with increased odds of stillbirth.
Authors: Catherine A Koss; Paul Natureeba; Julia Mwesigwa; Deborah Cohan; Bridget Nzarubara; Peter Bacchetti; Howard Horng; Tamara D Clark; Albert Plenty; Theodore D Ruel; Jane Achan; Edwin D Charlebois; Moses R Kamya; Diane V Havlir; Monica Gandhi Journal: AIDS Date: 2015-04-24 Impact factor: 4.177
Authors: E S Machado; C B Hofer; T T Costa; S A Nogueira; R H Oliveira; T F Abreu; L A Evangelista; I F A Farias; R T C Mercadante; M F L Garcia; R C Neves; V M Costa; J S Lambert Journal: Sex Transm Infect Date: 2008-11-05 Impact factor: 3.519
Authors: Benjamin H Chi; Lei Wang; Jennifer S Read; Taha E Taha; Moses Sinkala; Elizabeth R Brown; Megan Valentine; Francis Martinson; Robert L Goldenberg Journal: Obstet Gynecol Date: 2007-11 Impact factor: 7.661
Authors: Andreas D Haas; Lyson Tenthani; Malango T Msukwa; Kali Tal; Andreas Jahn; Oliver J Gadabu; Adrian Spoerri; Frank Chimbwandira; Joep J van Oosterhout; Olivia Keiser Journal: Lancet HIV Date: 2016-03-09 Impact factor: 12.767
Authors: Malango T Msukwa; Janne Estill; Andreas D Haas; Joep J van Oosterhout; Lyson Tenthani; Mary-Ann Davies; Kali Tal; Nozgechi Phiri; Adrian Spoerri; Bryan C Mthiko; Frank Chimbwandira; Olivia Keiser Journal: AIDS Date: 2018-09-24 Impact factor: 4.177
Authors: Eva M Rempis; Alexandra Schnack; Sarah Decker; Vera Braun; John Rubaihayo; Nazarius Mbona Tumwesigye; Priscilla Busingye; Gundel Harms; Stefanie Theuring Journal: BMC Pregnancy Childbirth Date: 2017-03-07 Impact factor: 3.007
Authors: Joy E Lawn; Hannah Blencowe; Peter Waiswa; Agbessi Amouzou; Colin Mathers; Dan Hogan; Vicki Flenady; J Frederik Frøen; Zeshan U Qureshi; Claire Calderwood; Suhail Shiekh; Fiorella Bianchi Jassir; Danzhen You; Elizabeth M McClure; Matthews Mathai; Simon Cousens Journal: Lancet Date: 2016-01-19 Impact factor: 79.321
Authors: Maxwell P Dapar; Benjamin N Joseph; Rotkangmwa C Okunlola; Josiah Mutihir; Moses P Chingle; Mathilda E Banwat Journal: Int J MCH AIDS Date: 2021-10-28
Authors: Nadia M Ikumi; Thokozile R Malaba; Komala Pillay; Marta C Cohen; Hlengiwe P Madlala; Mushi Matjila; Dilly Anumba; Landon Myer; Marie-Louise Newell; Clive M Gray Journal: AIDS Date: 2021-04-01 Impact factor: 4.177